Document is current
Any future updates will be listed below
-
Authors
Mu, Zhao https://orcid.org/0000-0002-0023-0637
Tang, Xiao https://orcid.org/0000-0003-3663-8690
Wang, Jingting https://orcid.org/0000-0002-6436-2620
Chen, Yulin https://orcid.org/0000-0001-5036-6199
Cui, Kui https://orcid.org/0000-0002-3489-6605
Rao, Xingyu https://orcid.org/0000-0003-2476-3064
Li, Juan https://orcid.org/0000-0002-0200-9258
Yang, Guodong https://orcid.org/0000-0003-3132-609X
-
Funding
Funding for this research was provided by:
the Hospital-level project of the Affiliated Hospital of North Sichuan Medical College (2022ZD005)
the Construction of Key Experimental Platform for Pancreatic Diseases in Sichuan Province (18SXHZ0371)
- License Information
-
More Information
Article History
Received: 23 September 2022
Accepted: 15 June 2023
First Online: 1 July 2023
Declarations
:
: The present study was performed at The Affiliated Hospital of North Sichuan Medical College under the Declaration of Helsinki. Verbal consent was obtained from the participants and approved by the ethics committee of The Affiliated Hospital of North Sichuan Medical College for this study(ethical batch number: 2022ER018-1).
: Not applicable.
: The authors have no conflict of interest to declare.
